Health Trials

Resin Infiltration Vs Self-Assembling Peptide (P11-4) in Treating White Spot Lesions

ConditionWhite Spot Lesion
Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age7-14
SponsorOctober 6 University

About this trial

Clinical assessment of the effectiveness of two treatment modalities (self-assembling peptide (P11-4) (alone or combined with fluoride) and resin infiltration) for treating white spot lesions

Eligibility criteria

Qualifiers

Age (a range from 7-14 years of age was determined)

Good general health (absence of disease/no handicaps, to ensure oral care at home)

Preserved pulp vitality of the teeth.

Consolidated oral care daily.

Disqualifiers

Patients with periodontal diseases (periodontal pockets or dental mobility) or radiologically identified pathologies (periapical radiolucency).

Teeth revealing any restorations were excluded from the current study.

Any previous or planned WSL treatment.

Trial design

Treatments tested in this trial

  • P11-4, a self-assembling peptide
  • P11-4, a self-assembling peptide with flouride
  • resin infilteration

Treatment groups

150 Participants
are divided into 3 treatment groups

Locations

1

Map coordinates are unavailable for these locations. Locations are shown below instead.

October 6 UniversityRecruiting Cairo, Giza GovernorateEgyptEgypt

Sponsors and collaborators

October 6 University

Lead sponsor

Al-Azhar University

Collaborator

University of Science and Technology of Fujairah

Collaborator

Source ClinicalTrials.gov